Welcome to LookChem.com Sign In|Join Free

CAS

  • or

24867-26-3

Post Buying Request

24867-26-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24867-26-3 Usage

Chemical Properties

Off-White Cyrstalline Solid

Uses

Different sources of media describe the Uses of 24867-26-3 differently. You can refer to the following data:
1. 2,4-Diamino-6-piperidinopyrimidine (Desoxyminoxidil) is an analogue of Minoxidil (M345000).
2. 2,4-Diamino-6-piperidinopyrimidine (Desoxyminoxidil) (Minoxidil EP Impurity E) is an analogue of Minoxidil (M345000).

Synthesis Reference(s)

Synthesis, p. 335, 1975 DOI: 10.1055/s-1975-23754

Check Digit Verification of cas no

The CAS Registry Mumber 24867-26-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,8,6 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 24867-26:
(7*2)+(6*4)+(5*8)+(4*6)+(3*7)+(2*2)+(1*6)=133
133 % 10 = 3
So 24867-26-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H13N5/c9-6-5-7(12-8(10)11-6)13-3-1-2-4-13/h5H,1-4H2,(H4,9,10,11,12)

24867-26-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Diamino-6-piperidinopyrimidine (Desoxyminoxidil)

1.2 Other means of identification

Product number -
Other names 6-piperidin-1-ylpyrimidine-2,4-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24867-26-3 SDS

24867-26-3Relevant articles and documents

Relative Reactivity in Piperidino-Dechlorination of 2,4-Diamino-6-chloropyrimidine, 2,4-Diamino-6-chloropyrimidine N(3)-Oxide, and Their Acetylamino Analogues

Maltese, M.

, p. 2436 - 2442 (1995)

The second-order rate constants kA for the piperidino-dechlorination of 2,4-diamino-6-chloropyrimidine (1a), 2,4-bis(acetylamino)-6-chloropyrimidine (1b), 2,4-diamino-6-chloropyrimidine N(3)-oxide (2a), and 2,4-bis(acetylamino)-6-chloropyrimidine N(3)-oxide (2b) have been determined from the corresponding pseudo-first-order rate constants, kψ, measured in DMSO at 21.0 deg C by the UV spectrophotometric procedure.The second-order rate coefficients of the less reactive substrates 1a and 2a at 21 deg C have been obtained as extrapolated values from Arrhenius plots of kA values, calculated through the psudo-first-order-type relationship, kψ = kA(where is the amine concentration),from the kψ measured at higher temperatures (kA(1a) = 1.36E-5 and kA(2a) = 3.44E-5 L mol-1 min -1).The reactivities of the acyl derivatives 1b and 2b are remarkably higher than that of the parent compounds 1a and 2a.The pseudo-first-order-rate constants of the more reactive substrates 1b and 2b, measured as a function of piperidine concentration, increase linearly for 1b, with a decreasing curvilinear slope only in the higher concentration region of base; in contrast, the reactivity of 2b remains almost constant and lower than that of 1b for most of the employed base concentrations.This behavior is due to the acidic character of compound 2b, which is almost totally transformed by excess piperidine into an anionic form, much less reactive than the protonated one toward the nucleophilic attack, even at relatively low base concentrations.Compound 1b is much less acidic than 2b and shows deviations from the second-order-type linear behavior only for the higher base concentrations.The equilibrium constant for the acid-base reaction of 2b with piperidine has been obtained spectrophotometrically (K= 0.007 +/- 0.001), and the second-order rate coefficient kA has been calculated from the constant apparent reactivity kψ by means of the formula kA = kψ/K (where is the piperidinium ion concentration) (kA(2b) = 2.7 L mol-1 min-1).That of 1b is given by the slope of the experimental curve kψ vs in the proximity of the origin (kA(1b) = 0.15 L mol-1 min-1).The results indicate that both the acetylation of the exocyclic -NH2 groups and the oxidation of the cyclic N(3)-atom increase the reactivity of the parent compounds toward piperidinolysis, but that the first modification is much more effective than the second one.The dependence of kψ of 1b and 2b on the amine concentration does not give any evidence for base catalysis, as expected in the model of the intermediate complex mechanism when the leaving group is fast to separate (as the -Cl group is) and/or the complex formation is rate-limiting.

Novel antiallergic agents. Part I: Synthesis and pharmacology of pyrimidine amide derivatives

Ban, Masakazu,Taguchi, Hiroaki,Katsushima, Takeo,Aoki, Shoichi,Watanabe, Akihiko

, p. 1057 - 1067 (2007/10/03)

We have synthesized many pyrimidine amide derivatives. Novel pyrimidine bis-glycolic amide derivatives showed moderate inhibition in the rat passive cutaneous anaphylaxis (PCA) assay by oral administration. Among these compounds, 2,4-bis(methoxyacetylamino)-6-piperidinopyrirnidine (2i) exhibited significant inhibition. However the compound (2i) did not inhibit antigen-induced histamine or SRS-A release from lung fragments of the guinea-pig at less than 10-4 M. Derivatives of 2i have also notable or moderate activity in the rat PCA assay. Compound 2h which has no oxygen atom at the α-position of the amide carbonyl group and, compound 17 which has no amide carbonyl group, showed no inhibition in the rat PCA assay. We supposed that both the amide carbonyl group and the oxygen atom at α-position of the amide carbonyl group play an important role in inhibiting the rat PCA reaction. These pyrimidine bis-glycolic amide derivatives have a novel structure and unique activity which suggests they may be potentially useful in the treatment of allergic diseases. Copyright (C) 1998 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24867-26-3